Fig. 3
From: Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
© 2017 by the authors
A Nanomedicines and tumor targeting. Nanomedicines must overcome various barriers to achieve efficient tumor-targeted drug delivery. B Mechanisms of tumor targeting mediated by nanomedicine, passive, active, triggered. Reproduced from Arranja et al. (2017), Copyright